These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10399096)

  • 21. A survey of use of unrelated volunteer donor bone marrow transplantation at 46 centres worldwide, 1989-93. International Marrow Unrelated Search and Transplant (IMUST) Study.
    Downie TR; Hows JM; Gore SM; Bradley BA; Howard MR
    Bone Marrow Transplant; 1995 Apr; 15(4):499-503. PubMed ID: 7655372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucopolysaccharidosis type II--genotype/phenotype aspects.
    Froissart R; Moreira da Silva I; Guffon N; Bozon D; Maire I
    Acta Paediatr Suppl; 2002; 91(439):82-7. PubMed ID: 12572848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA non-identical T-cell-depleted bone marrow transplantation for primary immunodeficiency diseases.
    Giri N; Vowels M; Ziegler JB; Ford D; Lam-Po-Tang R
    Aust N Z J Med; 1994 Feb; 24(1):26-30. PubMed ID: 8002854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.
    Davies SM; DeFor TE; McGlave PB; Miller JS; Verfaillie CM; Wagner JE; Weisdorf DJ
    Am J Med; 2001 Apr; 110(5):339-46. PubMed ID: 11286947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney.
    Atkinson K; Dodds AJ; Concannon AJ; Milliken S; Downs K; Marshall G; Wilson F; Staniforth D
    Aust N Z J Med; 1993 Oct; 23(5):450-7. PubMed ID: 8297273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).
    Alcalde-Martín C; Muro-Tudelilla JM; Cancho-Candela R; Gutiérrez-Solana LG; Pintos-Morell G; Martí-Herrero M; Munguira-Aguado P; Galán-Gómez E
    Eur J Med Genet; 2010; 53(6):371-7. PubMed ID: 20709629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of G-CSF in a patient with Hunter syndrome receiving bone marrow transplantation.
    Miniero R; Busca A; Vassallo E; Madon E
    Am J Hematol; 1994 Sep; 47(1):59-60. PubMed ID: 7518996
    [No Abstract]   [Full Text] [Related]  

  • 28. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
    La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
    Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors.
    Kanakry JA; Gocke CD; Bolaños-Meade J; Gladstone DE; Swinnen LJ; Blackford AL; Fuchs EJ; Huff CA; Borrello I; Matsui WH; Brodsky RA; Rosner GL; Shanbhag S; Luznik L; Jones RJ; Ambinder RF; Kasamon YL
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2115-2122. PubMed ID: 26183076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ten years' experience of bone marrow transplantation for Gaucher disease.
    Ringdén O; Groth CG; Erikson A; Granqvist S; Månsson JE; Sparrelid E
    Transplantation; 1995 Mar; 59(6):864-70. PubMed ID: 7701581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
    Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS).
    Burton BK; Whiteman DA;
    Mol Genet Metab; 2011 Jun; 103(2):113-20. PubMed ID: 21439875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localized donor cells in brain of a Hunter disease patient after cord blood stem cell transplantation.
    Araya K; Sakai N; Mohri I; Kagitani-Shimono K; Okinaga T; Hashii Y; Ohta H; Nakamichi I; Aozasa K; Taniike M; Ozono K
    Mol Genet Metab; 2009 Nov; 98(3):255-63. PubMed ID: 19556155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-myeloablative preconditioning with ACK2 (anti-c-kit antibody) is efficient in bone marrow transplantation for murine models of mucopolysaccharidosis type II.
    Yokoi T; Yokoi K; Akiyama K; Higuchi T; Shimada Y; Kobayashi H; Sato T; Ohteki T; Otsu M; Nakauchi H; Ida H; Ohashi T
    Mol Genet Metab; 2016 Nov; 119(3):232-238. PubMed ID: 27590924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years.
    Marks DI; Cullis JO; Ward KN; Lacey S; Syzdlo R; Hughes TP; Schwarer AP; Lutz E; Barrett AJ; Hows JM; Batchelor JR; Goldman JM
    Ann Intern Med; 1993 Aug; 119(3):207-14. PubMed ID: 8391772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow transplantation in patients with storage diseases: a developing country experience.
    Lange MC; Teive HA; Troiano AR; Bitencourt M; Funke VA; Setúbal DC; Zanis Neto J; Medeiros CR; Werneck LC; Pasquini R; Bonfim CM
    Arq Neuropsiquiatr; 2006 Mar; 64(1):1-4. PubMed ID: 16622543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucopolysaccharidosis type II (Hunter's syndrome) in Taiwan.
    Su PH; Hwu WL; Chiang SC; Chiu PC; Lin SJ; Shu SG; Wang TR
    J Formos Med Assoc; 1998 Mar; 97(3):186-90. PubMed ID: 9549269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The management of children with Hunter syndrome - a case study.
    Little C; Gould R; Hendriksz C
    Br J Nurs; 2009 Mar 12-25; 18(5):321-2. PubMed ID: 19273994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
    Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.